ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXPLORES EUROPEAN COOPERATION IN HEALTH TECHNOLOGY ASSESSMENT

Published Oct 31, 2016
Vienna, Austria—31 October 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR)  facilitated a discussion on National Health Technology Assessment (HTA) Process and European Cooperation on HTA: Fit for Purpose? this morning at the Society’s 19th Annual European Congress in Vienna, Austria.  The panel was moderated by Finn Børlum Kristensen, MD, PhD, Professor, University of Southern Denmark, Hilleroed, Denmark. Speakers for the discussion panel included:
  • Dominik Schnichels, Head of Unit, DG SANTE B4, Medical Products: Quality, Safety, Innovation, European Commission, Brussels, Belgium
  • Zoe Garrett, MRes, Senior Technical Adviser, Centre for Health Technology Evaluation, National Institute for Health and Care Excellence, Manchester, UK
  • Rui Santos Ivo, Vice-President, Executive Board, National Authority of Medicines and Health Products, Lisbon, Portugal
  • Tomas Tesar, PharmD, PhD, MBA, Member, Reimbursement Committee, Union Health Insurance Fund, Bratislava, Slovakia
The panelists acknowledged that while decision making on patient access to health technologies will remain a sole national competence of the European Union (EU) Member States, they stressed that opportunities do exist to improve European cooperation on HTA. Through the work of EUnetHTA, European cooperation on HTA has resulted in methodological and process support tools that facilitate collaborative scientific work and production of HTA information that can be shared across borders. The speakers discussed a number of important issues that could contribute to a permanent solution for sustainable HTA cooperation in Europe, including: - identifying ways in which the collaborative work produced at the European level can fit into national HTA and decision-making processes - creating processes to ensure that European cooperation effectively and efficiently contributes to HTA in participating countries - exploring opportunities and plans that can support synergy between European and national HTA processes - developing strategies to support regional cooperation between Member States and the EU Additional information on the ISPOR 19th Annual European Congress can be found here. Released presentations from the congress can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORVienna.

###

Related Stories

Measuring What Matters: Broadening the Scope of Health Economics Evaluation to Incorporate Well-Being

Jul 9, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate well-being into decision making.

Confronting the Backlash Against QALYs: Key Insights From Leading Health Economists

Jun 18, 2024

ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making.

ISPOR Good Practices Report Offers Guidance for Using Real-World Data From EHRs in Health Technology Assessments

Jun 17, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that proposes a framework for assessing the suitability of electronic health records data for use in health technology assessments. The report, “Assessing Real-World Data from Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force” was published in the June 2024 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×